Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Russia trials COVID-19 vaccine for domestic animals, including mink

Russia trials COVID-19 vaccine for domestic animals, including mink

MARIA VASILYEVA RUSSIA is close to completing clinical trials for a COVID-19 vaccine for domestic animals and mink and expects to begin the regulatory approval process in February, according to Russia's agricultural safety watchdog. The Federal Centre for Animal Health began developing the vaccine in spring after the authorities established the virus could be passed from humans onto some domestic animals. Russia became the first country to give regulatory approval to a human vaccine -- Sputnik V -- in August and is in the process of rolling it out across the country. Over 150,000 people have already received it. The…
Read More
Morocco orders COVID-19 vaccine as cases approach 100,000

Morocco orders COVID-19 vaccine as cases approach 100,000

MOROCCO has signed a deal with Russia's R-Pharm to buy a COVID-19 vaccine produced under a licence from Britain's AstraZeneca, the health ministry said, as its total number of cases approached 100,000. The Ministry did not provide details on the cost and quantity of the order. AstraZeneca licensed R-Pharm in July to produce the vaccine it developed together with Oxford University. This month, Morocco started taking part in clinical trials of China's Sinopharm vaccine. The North African country added a daily record 2,760 cases to its confirmed total on Friday, meaning it has recorded 97,264 in all, including 1,755 deaths.…
Read More
Oxford scientists: these are final steps we’re taking to get our coronavirus vaccine approved

Oxford scientists: these are final steps we’re taking to get our coronavirus vaccine approved

REBECCA ASHFIELD, Senior Project Manager, Jenner Institute, University of Oxford PEDRO FOLEGATTI, Clinical Research Fellow at the Centre for Clinical Vaccinology and Tropical Medicine, Jenner Institute, and PhD Candidate in Clinical Medicine, University of Oxford OF the hundreds of potential COVID-19 vaccines in development, six are in the final stages of testing, known as phase 3 clinical trials. One of these – ChAdOx1 nCoV-19 – is the vaccine we’re developing at the University of Oxford. To be approved, vaccines need to go through multiple rounds of testing to show that they’re safe and effective. A combined phase 1 and phase…
Read More